Tocilizumab, a humanized anti-IL.6 receptor antibody, has been approved as a biological drug for the treatment of rheumatoid arthritis, Castleman's disease and systemic JIA, and is expected to be ...
Polymyalgia rheumatica (PMR) is a common inflammatory condition affecting elderly people and involving the girdles. [1] The mainstay of treatment is oral glucocorticoids (GC), with the recent BSR ...